Kohei Takatsuka

Kohei Takatsuka is the Associate Director of Strategy & Operations at Iterative Health, leading the Go-To-Market strategy for the FDA cleared AI-enabled polyp detection device, SKOUT. Prior to this, Kohei worked as a Summer Associate at Sozo Ventures and Genentech, focusing on investment analysis and marketing strategy respectively. With previous experience as a Consultant at Boston Consulting Group, Kohei has a broad project background in supporting Biopharma in Japan and the US, including product launch strategy and corporate strategy development. A graduate of Harvard Business School and Grinnell College, Kohei brings a strong education background to their current role.